Kleczko, E. K., & Heasley, L. E. (2018). Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities. Mol Cancer.
Citação norma ChicagoKleczko, Emily K., and Lynn E. Heasley. "Mechanisms of Rapid Cancer Cell Reprogramming Initiated By Targeted Receptor Tyrosine Kinase Inhibitors and Inherent Therapeutic Vulnerabilities." Mol Cancer 2018.
Citação norma MLAKleczko, Emily K., and Lynn E. Heasley. "Mechanisms of Rapid Cancer Cell Reprogramming Initiated By Targeted Receptor Tyrosine Kinase Inhibitors and Inherent Therapeutic Vulnerabilities." Mol Cancer 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.